Clinical Trial Update: The Tracking Molecular Evolution for NSCLC (T-MENC) Study

View source ↗

Summary

An update on the Tracking Molecular Evolution for non-small cell lung cancer (T-MENC) trial, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Geneplus-Beijing Co. Ltd. | Conditions: Lung Neoplasms, Lung Cancer | Status: UNKNOWN